For the North-American and European population, ANA and SMA constitute the standard repertoire for the diagnosis of autoimmune hepatitis, and AMA is the diagnostic marker of primary biliary cirrhosis [7,16]. This evidence concerns the gene SMN1 and primary biliary cholangitis.